AINOS INC (AIMD)
NASDAQInformation TechnologyBiotechnologySnapshot 2026-11-04
NASDAQInformation TechnologyBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · AIMD
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 66 industry peers
AIMD — legal / regulatory event — Changes in Registrant’s Certifying Accountant
Dated 2026-07-10
Changes in Registrant’s Certifying Accountant. Following the expiration of the engagement with YCM CPA INC. (“YCM”), the Company’s independent registered public accounting firm, on July 9, 2026, the Company dismissed YCM as the Company’s independent registered public accounting firm. On the same day, the audit committee of the board of directors of the Company (the “Audit Committee”) engaged DLEE Accountancy, Inc. (“ DLEE ”) as the Company’s new independent registered public accounting firm,…
Why it matters: The license creates a specific payment test. The Q2 results did not show license revenue, so payment would confirm delivery of a stated deal term.
Supportive ifA filing or earnings report confirms payment of the $600,000 initial license fee. It records the related revenue.
Worry ifThe next earnings report still shows no payment or license revenue. Or, the company reports that payment conditions were not met.
Why it matters: Q2 operating expenses rose to $4.40 million from $2.28 million in Q1. A lower Q3 figure would show spending has eased.
Supportive ifQ3 operating costs are below $4.40 million. The operating loss is also below $4.40 million.
Worry ifQ3 operating costs remain at or above $4.40 million. Or, the operating loss grows beyond $4.40 million.
Why it matters: Cash was $1.42 million at Q2 end, while Q2 operating loss was $4.40 million. A further cash drop without new funding would raise pressure on the company.
Worry ifA filing shows cash below $1.42 million and no new financing or partner payment reported.
Less concerning ifCash stays at or above $1.42 million, with new funding or a reported partner payment helping support cash.
Why it matters: The deal is a named commercial test for AI Nose. More systems in use and revenue tied to the deal would show progress beyond pilots.
Supportive ifA company update reports more systems deployed under the $2.1 million deal. It also records related revenue.
Worry ifThe next update reports no added deployments or revenue tied to the deal.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$253 on $10,000 · ±2.5% | How much price usually moves either way. |
| Bad day | $1,047 loss on $10,000 · 10.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,110 loss on $10,000 · 81.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Q2 revenue was only $152. Revenue above that level would show early progress toward broader sales in the second half of 2026.
Supportive ifOn November 12, Q3 results show AI Nose revenue above $152. The company reports paid customer use.
Worry ifQ3 revenue is $152 or less, with no reported paid customer use.